Stay updated on Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe page’s displayed software/version label has been updated from Revision v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedVersion 2026-03-25 introduces QC status and adds multiple sections to the record, including More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and updated Study Status. It also expands the Documents/Document Section area to provide additional references and contacts for the study.SummaryDifference0.8%

- Check42 days agoChange DetectedRevision: v3.5.0 was added to the history. Revision: v3.4.3 was removed from the history.SummaryDifference0.1%

- Check50 days agoChange DetectedThe history now shows 'Results Submitted' replacing 'No Results Posted', and the page revision is updated to v3.4.3.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history adds Revision: v3.4.2 and removes Revision: v3.4.1. This reflects a minor version update in the history.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Combo vs Higher Insulin Alone in Type 2 Diabetes Clinical Trial page.